green tick

Improvements in prescribing creates savings: NPS

0 comments Read Later

Improvements in prescribing creates savings: NPS

Falling rates of prescribing of high dose statins and anti-dementia drugs is proof that programs aimed at improving the quality use of medicines are effective, NPS MedicineWise believes.

The NPS MedicineWise claimed credit for “improvements in appropriate prescribing” of the drugs in its annual evaluation report, released yesterday.

Dr Lynn Weekes (pictured), NPS MedicineWise CEO, said the report outlined the organisation’s success in creating both health and economic impacts.

“I’m proud of the good work we have done in the past financial year to enable people to make the best decisions about medicines and other medical choices to achieve better health and economic outcomes,” she said.

In a statement, NPS MedicineWise said the report showed that programs it delivered had had considerable health impacts in improving prescribing and cardiovascular management, and in encouraging adherence to pharmacological treatment among patients with diabetes.

“It also explains that there have been improvements in inappropriate prescribing, for example a 7% relative decrease in prescribing of high-dose statins and [a] 10% decrease in anti-dementia drugs was observed in the financial year,” the statement said.

“The evaluations of two therapeutic programs—'CVD risk: guiding lipid management' and 'Balancing benefits and harms of antipsychotic therapy'—found there were improvements in knowledge and practice changes among health professionals.”

Highlights from the Annual Evaluation Report 2012/13

  • NPS MedicineWise has been successful in creating both health and economic impacts. Programs delivered in primary care over the past decade have had considerable health impacts in terms of improving prescribing and service use in cardiovascular management and encouraging adherence to pharmacological treatment among patients with diabetes. 
  • There have been improvements in appropriate prescribing, for example a 7% relative decrease in prescribing of high-dose statins and 10% decrease in anti-dementia drugs was observed in the financial year.
  • The program evaluations of the two therapeutic programs, 'CVD risk: guiding lipid management' and 'Balancing benefits and harms of antipsychotic therapy' found there were improvements in knowledge and practice change among health professionals. 
  • The evaluation of two programs aimed at improving quality use of medicines training in Aboriginal Community Controlled Health Sector programs succeeded in significantly increasing and improving knowledge, skill, attitudes and confidence of participants.
  • A total of 22,349 unique health professionals participated in our programs during the year. 
  • Overall, 57% of registered GPs in Australia have participated in an NPS MedicineWise intervention in the year. 
  • NPS MedicineWise has also a significant internet presence with 1.2 million visits to our website and 1.3 million Twitter and Facebook views in the last year. 
 

 

 Subscribe to our Newsletter


 Breaking news and special features
 A daily must-read for pharmacists
 Delivered to your inbox
By filling in your email address and clicking submit with this option selected, you agree to receive email communications from us relevant to the healthcare industry. You always have the option of unsubscribing later via an unsubscribe link or your subscriptions management page. View our privacy policy here.

Your profile is
0% complete


 
 

Pharmacy News on Twitter

­

My list
  •  
Read Later